Coverys Healthtech E&O Review: The Honest Take for CT Clinical-AI Founders (2026)
Coverys is the carrier that exists because the rest of the insurance market refused to insure clinical AI. For a Connecticut healthtech building anything that influences a clinician's treatment decision — radiology assist, sepsis early-warning, dosing calculators, AI-powered triage — Coverys is the carrier you end up at after every other quote comes back as a decline or a useless exclusion-stacked offer.
This is an honest review. Coverys is the right answer for a specific lane and the wrong answer outside it. Get it right and you have a carrier that defends clinical claims with actual MDs and MPL specialists. Get it wrong and you've spent 8 weeks in underwriting purgatory for a policy that costs 3x what Beazley would have charged you.
Quick verdict: Coverys is the best-in-class Healthtech E&O placement for Tier 3 and Tier 4 CT healthtech — clinical decision support, SaMD, FDA-cleared diagnostic AI. They write a blended Tech E&O + Medical Malpractice form on one tower, which is the only sane structure when a missed sepsis alert ends in a wrongful death suit. Skip Coverys if you're Tier 1/2 (Hiscox or Beazley is faster and cheaper) or if you don't yet have clinical validation data (they'll decline).
What Coverys' Healthcare Technology MPL form actually is
Coverys started as a Massachusetts-based Medical Professional Liability carrier — they insure CT hospital systems and physician groups directly. In the mid-2010s, when clinical AI vendors started getting deployed inside the systems Coverys already insured, they built a dedicated Healthcare Technology MPL form specifically because legacy Tech E&O carriers (Hiscox, Travelers, even Beazley) wouldn't touch the risk.
The form blends:
- Tech E&O — software defect, integration failure, downtime, software-as-a-service obligations.
- Medical Professional Liability (MPL) — bodily injury claims arising from the use of your technology in clinical care. This is the piece nobody else writes well.
- Cyber Liability — including HIPAA-aware breach response on a tighter sublimit than Beazley but still credible.
- Products Liability extension for FDA-cleared SaMD.
- Regulatory / HIPAA OCR defense within the cyber section.
Crucially, claims that allege both a software error and bodily injury (the typical clinical-AI claim) pay out under a single tower instead of triggering a coverage fight between two separate carriers. That single-tower structure is what makes Coverys worth the premium.
What's actually covered (the honest version)
| Coverage Area | Standard Limit | Maximum Limit | Quality Grade |
|---|---|---|---|
| Blended Tech E&O + MPL | $1M–$3M per claim | $15M (with reinsurance) | A+ (no real competition outside MedPro) |
| Aggregate | $3M–$5M | $25M | A |
| Cyber 1st-party | $1M | $5M | B+ (good, not Beazley-level) |
| HIPAA OCR defense & fines | $500K sublimit | $2M sublimit | A |
| Products Liability (SaMD) | $1M / $2M | $10M / $10M | A (unique in market) |
| Defense costs | Outside limits (preferred) | N/A | A+ (defense-outside-limits is the gold standard) |
| Crisis management / PR | $100K–$250K sublimit | $500K sublimit | B+ |
Defense costs outside limits is the single most valuable feature on this form. When a clinical-AI claim goes to litigation, defense costs alone can hit $500K–$2M before a verdict — and on a defense-inside-limits form, that money eats into the indemnity you needed for the actual settlement. Coverys' defense-outside structure means a $5M limit actually pays $5M in indemnity, with defense paid separately.
What's not covered — the gap list
- Pre-clinical-validation products. If you haven't run real-world validation studies or clinical pilots, Coverys will likely decline the submission. They want to see outcomes data — not a pitch deck.
- Direct-to-consumer health products without clinical oversight. A consumer wellness app sold direct-to-consumer with no clinician in the loop is not a Coverys risk. Hiscox or Tokio Marine fits better.
- Patent infringement. Excluded across the form. Copyright/trademark covered with sublimit.
- Crypto / blockchain / digital asset losses. Hard exclusion. Coverys has no appetite for healthcare-blockchain products.
- Acts of state regulators outside healthcare. FTC, SEC, state AG actions outside the healthcare context are excluded. HHS OCR, CMS, and state DOH actions are covered within the regulatory sublimit.
- Insolvency of your hospital customer. If your CT hospital customer goes bankrupt before paying you, that's a credit risk, not an E&O claim.
- Acts outside FDA clearance scope. If your 510(k) clears the device for one indication and you market it for an off-label use that causes harm, the off-label use is excluded.
Pro tip: Coverys' underwriters are physicians. The submission package needs to be written for a clinician audience, not an insurance audience. We routinely help CT healthtech founders rewrite their submission narrative to emphasize clinical validation methodology, false-positive/false-negative rates, human-in-the-loop design, and post-market surveillance — not "our AI is 99.9% accurate." That single rewrite often moves a submission from "declined" to "quoted."
Pricing — what CT healthtech founders actually pay
Coverys pricing in 2026, Tier 3/4 healthtech (clinical decision support or SaMD with clinical validation data):
| Stage | Clinical Exposure | Typical Limits | Annual Premium |
|---|---|---|---|
| Pre-revenue (post-pilot) | First clinical deployments | $1M / $3M | $25,000–$40,000 |
| Seed / early commercial | 3–10 hospital customers | $2M / $4M | $40,000–$75,000 |
| Series A | 10–50 hospital customers | $3M–$5M / $5M | $75,000–$150,000 |
| Series B | 50+ hospital customers, SaMD | $5M–$10M / $10M | $150,000–$300,000 |
| Series C+ | Enterprise SaMD at scale | $10M+ towers | $300,000+ |
These premiums are 3–5x what a Hiscox Tier 1 wellness policy would cost. They're also 1/10th of what an uncovered $10M Med Mal verdict looks like. Healthtech founders consistently underestimate clinical claim severity until they see a Coverys submission package with actual loss data attached.
Coverys vs. the alternatives (CT healthtech shortlist)
| Carrier | Best Fit Tier | Strength | Watch Out For |
|---|---|---|---|
| Coverys | Tier 3, Tier 4 | Clinical AI form, MD underwriters, defense-outside-limits | Slow, requires validation data |
| MedPro | Tier 3, 4, 5 | Highest limits, Berkshire balance sheet, best defense bench | Conservative appetite for pre-validation products |
| Beazley | Tier 2 | Best HIPAA breach response, fast | Won't write Tier 3+, no MPL component |
| Tokio Marine HCC | Tier 2, borderline Tier 3 | Negotiates AI exclusions, Series A friendly | No SaMD appetite |
| Hiscox | Tier 1 | Speed, low price | Hard pass on clinical decision support |
| CNA | Tier 2, Tier 3 | Hospital procurement comfort | Less clinical underwriting depth than Coverys |
Who Coverys is the right call for
- Connecticut healthtech, Tier 3 (clinical decision support) or Tier 4 (SaMD).
- Real clinical validation data — at minimum a published pilot or peer-reviewed validation study.
- Hospital or health-system customers (CT hospitals especially — Yale New Haven, Hartford HealthCare, Trinity Health New England).
- Founder willing to invest 6–10 weeks in underwriting for a substantively better form.
- FDA-cleared (or actively pursuing 510(k)) SaMD vendors.
- Anything where a software output could foreseeably cause patient harm — that's the Coverys-vs-everyone-else line.
Our verdict
If your CT healthtech sits in Tier 3 or Tier 4 — anything that influences clinical decision-making or carries FDA clearance — Coverys is the carrier. The slow underwriting is a feature, not a bug; you want MDs reviewing this risk. Pay the premium, supply the validation data, and rest easy that when (not if) a clinical claim lands, the carrier is built to defend it.
The Connecticut hospital connection
Coverys insures a meaningful share of the CT hospital system itself on the provider-MPL side — covering CT physician groups, employed clinicians, and select health-system entities. That matters for CT healthtech founders in two ways:
- Their actuarial data on CT clinical risk is best-in-class. When pricing your CT healthtech, they're not extrapolating from out-of-state loss data — they're pricing against actual CT verdict patterns.
- Hospital procurement recognition. A CT health system's Risk Management team already knows Coverys. When you present a Coverys COI as part of vendor onboarding, the friction at procurement drops noticeably.
Key Takeaways
- Coverys is the Tier 3 / Tier 4 default for CT clinical AI and SaMD. No real competition outside MedPro.
- Blended Tech E&O + MPL on a single tower is the killer feature — one carrier defends the claim no matter how it's pled.
- Defense-outside-limits is the gold-standard structure for clinical claims and is included as standard.
- Slow underwriting (6–10 weeks) — bake the timeline into your funding and contract close timelines.
- You need real clinical validation data to get past first review — not a pitch deck.
- Skip Coverys for Tier 1/2 healthtech — Beazley, Hiscox, or Tokio Marine fits better and faster.
Frequently Asked Questions About Coverys Healthtech E&O
Is Coverys admitted in Connecticut?
Yes. Coverys writes the Healthcare Technology MPL form on an admitted basis in CT. The carrier is rated A by A.M. Best and has long-standing relationships with the CT Insurance Department from the provider-MPL business.
Do I need clinical pilot data before submitting to Coverys?
Effectively yes. Coverys will accept a submission without published data, but the underwriter will ask for it — and in the absence of validation, they'll usually decline or quote with severe exclusions. Run at least one credible clinical pilot (CT hospital, IRB-approved if possible) before submitting.
Will Coverys cover my CT telehealth platform with employed clinicians?
That's a Tier 5 risk and Coverys can write it, but MedPro is usually the stronger primary for provider-embedded telehealth. Coverys typically sits as co-primary or excess in those placements.
How long does a Coverys clinical-AI submission take?
Realistic timeline: 6–10 weeks from clean submission to bind. Triage and MD review takes 4–6 weeks; quote acceptance and binding takes another 2–4. Plan 12 weeks if your data package or 510(k) documentation is still being assembled.
Will Coverys cover a Yale-spinout AI radiology vendor?
This is exactly the lane Coverys was built for. Yale-spinout radiology AI with published validation, IRB-approved deployment, and CT hospital pilots is a textbook Coverys submission. Expect $50K–$120K in annual premium for $3M–$5M limits at pre-Series A scale.
Can I have Coverys primary and Beazley excess on cyber?
Yes — and we structure this regularly. Coverys' cyber sublimit is competent but Beazley's BBR is best-in-class. Putting Beazley as excess cyber above Coverys primary gives you Coverys' clinical defense bench on E&O/MPL claims and Beazley's incident response on cyber events. Premium delta is usually $10K–$25K for the layered structure.
More from this series
Want a real Coverys submission package?
iConn Insurance Solutions packages CT healthtech submissions for Coverys, MedPro, Beazley, Tokio Marine HCC, and CNA. We'll help you build the clinical validation narrative that gets a quote — not a decline.
Get a Healthtech E&O quoteiConn Insurance Solutions is an independent CT insurance agency. We're appointed across the healthtech carrier spectrum and have no incentive to push any single market.